Debating drug prices

Clinton advisors debate pharma advocates on drug pricing

A recent debate pitting two of the Democratic Party’s leading health policy experts against pharma advocates provides a glimpse of how a Hillary Clinton administration would follow through on her promise to rein in prescription drug prices.

On Oct. 13 at an Intelligence Squared debate in New York, Clinton advisors Neera Tanden and Ezekiel Emanuel squared off against PhRMA’s Lori Reilly and the Manhattan Institute for Policy Research’s Paul Howard to debate the motion that drug prices are fueling runaway healthcare costs.

Tanden and Emanuel - who are certain to be influential in a Clinton administration - spent little time debating the impact of drug prices on overall healthcare costs. Instead, they highlighted the struggles of individual patients to pay for life-saving medicines and argued that lower prices in other countries, as well as high drug company profit margins, are proof

Read the full 1403 word article

User Sign In